Prosperity Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
1,374
-113
-8% -$115K 0.08% 146
2026
Q1
$1.37M Sell
1,487
-3,039
-67% -$3.08M 0.08% 156
2025
Q4
$4.86M Sell
4,526
-898
-17% -$859K 0.29% 74
2025
Q3
$4.14M Buy
5,424
+3,879
+251% +$2.89M 0.24% 75
2025
Q2
$1.2M Buy
1,545
+312
+25% +$242K 0.08% 160
2025
Q1
$993K Sell
1,233
-255
-17% -$212K 0.08% 156
2024
Q4
$1.15M Buy
1,488
+95
+7% +$78.7K 0.09% 147
2024
Q3
$1.23M Buy
1,393
+175
+14% +$157K 0.11% 137
2024
Q2
$1.1M Sell
1,218
-422
-26% -$338K 0.12% 125
2024
Q1
$1.28M Buy
1,640
+447
+37% +$318K 0.15% 114
2023
Q4
$696K Buy
1,193
+185
+18% +$108K 0.08% 130
2023
Q3
$541K Buy
1,008
+262
+35% +$135K 0.07% 132
2023
Q2
$350K Hold
746
0.05% 174
2023
Q1
$256K Sell
746
-2
-0.3% -$675 0.04% 176
2022
Q4
$274K Buy
+748
New +$265K 0.08% 154

Other funds holding LLY

Prosperity Capital Advisors's LLY Position: Q2 2026 in Review

Prosperity Capital Advisors reduced its Eli Lilly (LLY) stake by 7.6% in Q2 2026, selling an estimated $115K and leaving 1,374 shares worth $1.65M. The position accounts for 0.08% of the portfolio, ranked #146.

Prosperity Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.86M in Q4 2025. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prosperity Capital Advisors held 1,374 shares of Eli Lilly worth $1.65M as of Q2 2026.
  • Prosperity Capital Advisors sold 113 Eli Lilly shares in Q2 2026, an estimated $115K.
  • Eli Lilly made up 0.08% of Prosperity Capital Advisors's portfolio in Q2 2026, its #146 holding.
  • Prosperity Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Prosperity Capital Advisors's Eli Lilly position peaked at $4.86M in Q4 2025.
  • 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.